Fatal Familial Insomnia News and Research

RSS
CHARMs: A new hope for prion disease therapy

CHARMs: A new hope for prion disease therapy

Curcumin nanoparticles show promise in treating neurodegenerative diseases

Curcumin nanoparticles show promise in treating neurodegenerative diseases

Brain changes can be studied in very early stages of neurodegenerative diseases

Brain changes can be studied in very early stages of neurodegenerative diseases

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

NPDPSC at Case Western Reserve University to receive CDC funding for better understanding of prion diseases

New breakthrough may help cure prion disease

New breakthrough may help cure prion disease

Mice study illustrates potential risks associated with prion transmission

Mice study illustrates potential risks associated with prion transmission

New research shows how to prevent prions from growing into deadly diseases

New research shows how to prevent prions from growing into deadly diseases

Prion protein could play a role in depression

Prion protein could play a role in depression

Researchers create mouse models to advance the study of unusual deadly diseases

Researchers create mouse models to advance the study of unusual deadly diseases

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

Scientists take important step toward pharmacologic development of treatment for fatal brain disorders

Normal protein can be converted into prion that causes fatal brain diseases in humans

Normal protein can be converted into prion that causes fatal brain diseases in humans

Mutations associated with prion diseases are sufficient to cause transmissible neurodegenerative disease

Mutations associated with prion diseases are sufficient to cause transmissible neurodegenerative disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.